Accessibility Menu
 
Xoma Royalty logo

Xoma Royalty

(NASDAQ) XOMAP

Current Price$25.30
Market CapN/A
Since IPO (2020)+75%
5 Year+65%
1 Year+13%
1 Month+7%

Xoma Royalty Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$52.15M

Net Income (TTM)

$31.71M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$2.16

Beta (Volatility)

0.08 (Low)

Price

$25.30

Volume

157

Open

$27.25

Previous Close

$27.25

Daily Range

$27.25 - $27.25

52-Week Range

$24.96 - $30.00

XOMAP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Xoma Royalty

Industry

Biotechnology

Headquarters

EmeryVille, CA 94608, US

XOMAP Financials

Key Financial Metrics (TTM)

Gross Margin

94%

Operating Margin

22%

Net Income Margin

56%

Return on Equity

0%

Return on Capital

5%

Return on Assets

11%

Earnings Yield

N/A

Dividend Yield

0.08%

Payout Ratio

18.61%

Stock Overview

Market Cap

$0.00

Shares Outstanding

0

Volume

157

Short Interest

0.00%

Avg. Volume

925.377

Financials (TTM)

Gross Profit

$49.19M

Operating Income

$11.38M

EBITDA

$14.36M

Operating Cash Flow

$2.87M

Capital Expenditure

$0.00

Free Cash Flow

$2.87M

Cash & ST Invst.

$82.91M

Total Debt

$131.56M

Xoma Royalty Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$13.76M

+57.9%

Gross Profit

$13.62M

+60.0%

Gross Margin

99.02%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

13

N/A

Net Income

$6.10M

+253.8%

EBITDA

$4.75M

+21.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$48.65M

-247.1%

Accounts Receivable

$4.90M

-71.2%

Inventory

$0.00

N/A

Long Term Debt

$116.56M

+8.6%

Short Term Debt

$14.99M

+26.6%

Return on Assets

10.79%

N/A

Return on Invested Capital

4.79%

N/A

Free Cash Flow

$5.50M

-89.3%

Operating Cash Flow

$5.50M

-89.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TECXTectonic Therapeutic, Inc.
$31.09+3.43%
ALDXAldeyra Therapeutics, Inc.
$1.59+1.27%
AMRNAmarin Corporation plc
$14.78+0.34%
ACIUAC Immune S.A.
$3.40+5.92%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$48.96+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.45+0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$67.86-0.02%
NOKNokia
$9.55+0.01%

Questions About XOMAP

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.